Lewes, DE -- (SBWIRE) -- 02/18/2015 -- Report forecast the API market in the US to grow at a CAGR of 7.01 percent over the period 2014-2019.

Active pharmaceutical ingredients (API) are active substances that are used in the manufacture of drugs and that have pharmacological effects. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. API may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology and for treatment of conditions such as respiratory disorders and rheumatoid arthritis.

The report covers the present scenario and the growth prospects of the API market in the US for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of API by vendors in the market. It provides the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The market segmentation is carried out on the basis of: type of production process (synthetic production process and biotechnology-based production process), type of product (conventional API and high-potency API), and type of players (captive and merchant).

The report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

The API Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

Key Vendors
- Abbott Laboratories
- Aurobindo Pharma
- Mylan
- Teva Pharmaceutical Industries

Other Prominent Vendors
- Albemarle
- Aptuit
- BASF
- Biocon
- Boehringer Ingelheim
- Cambrex
- Cipla
- Dr. Reddy's Laboratories
- Hospira
- Lonza Group
- Novartis
- Pfizer
- Sigma-Aldrich
- Sun Pharmaceutical Industries

Market Driver
- Strong Preference for Generic Drugs
- For a full, detailed list, view our report

Market Challenge
- Decrease in R&D Spending
- For a full, detailed list, view our report

Market Trend
- Strong Focus on High-potency API
- For a full, detailed list, view our report

Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 65 pages, "Active Pharmaceutical Ingredients (API) Market in the US 2015-2019" report covering the Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Market Landscape, API Market in the US, Market Segmentation by Type of Production Process, Market Segmentation by Type of Product, Market Segmentation by Type of Players, Buying Criteria, Market Growth Drivers, Drivers and their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and their Impact, Vendor Landscape, Key Vendor Analysis. The report covered companies are – Abbott Laboratories, Aurobindo Pharma, Mylan,Teva Pharmaceutical Industries, Albemarle, Aptuit, BASF, Biocon, Boehringer Ingelheim, Cambrex, Cipla,Dr. Reddy's Laboratories, Hospira, Lonza Group, Novartis, Pfizer, Sigma-Aldrich, Sun Pharmaceutical Industries

For further information on this report, please visit- http://www.marketresearchreports.com/technavio/active-pharmaceutical-ingredients-api-market-us-2015-2019

Find all Petrochemicals Reports at: http://www.marketresearchreports.com/petrochemicals

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

For regular industry updates subscribe to our newsletter at:
http://www.marketresearchreports.com/subscribe-to-newsletter